Details for Patent: 9,504,647
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 9,504,647 protect, and when does it expire?
Patent 9,504,647 protects NOCDURNA and is included in one NDA.
This patent has forty-three patent family members in twenty-nine countries.
Summary for Patent: 9,504,647
| Title: | Pharmaceutical formulations of desmopressin |
| Abstract: | Good bioavailability of desmopressin can be obtained by means of an orodispersible pharmaceutical dosage form. Preferred dosage forms comprise desmopressin and an open matrix network which is an inert water-soluble or water-dispersible carrier material. Desmopressin formulated in this way is useful for voiding postponement, or the treatment or prevention of incontinence, primary noctural enuresis (PNE), nocturia or central diabetes insipidus. Peptides other than desmopressin can also be formulated in this way. |
| Inventor(s): | Nilsson; Anders (Lund, SE), Lindner; Hans (Berlin, DE), Wittendorff; Jorgen (Hvidovre, DK) |
| Assignee: | FERRING B.V. (Hoofddorp, NL) |
| Application Number: | 14/947,261 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,504,647 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Process; Dosage form; |
Drugs Protected by US Patent 9,504,647
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ferring Pharms Inc | NOCDURNA | desmopressin acetate | TABLET;SUBLINGUAL | 022517-001 | Jun 21, 2018 | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | TREATMENT OF NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | See Plans and Pricing | |||
| Ferring Pharms Inc | NOCDURNA | desmopressin acetate | TABLET;SUBLINGUAL | 022517-002 | Jun 21, 2018 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | TREATMENT OF NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | See Plans and Pricing | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,504,647
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 039092 | See Plans and Pricing | |||
| Argentina | 039794 | See Plans and Pricing | |||
| Argentina | 107948 | See Plans and Pricing | |||
| Austria | 333886 | See Plans and Pricing | |||
| Australia | 2002337419 | See Plans and Pricing | |||
| Australia | 2003233118 | See Plans and Pricing | |||
| Australia | 2003299480 | See Plans and Pricing | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
